Hugo Maas
Boehringer Ingelheim (Germany)(DE)
Publications by Year
Research Areas
Atrial Fibrillation Management and Outcomes, Cardiac Arrhythmias and Treatments, Venous Thromboembolism Diagnosis and Management, Migraine and Headache Studies, Blood Coagulation and Thrombosis Mechanisms
Most-Cited Works
- → Dabigatran versus Warfarin in Patients with Mechanical Heart Valves(2013)1,485 cited
- → Model of Chemotherapy-Induced Myelosuppression With Parameter Consistency Across Drugs(2002)525 cited
- → A set-point model with oscillatory behavior predicts the time course of 8-OH-DPAT-induced hypothermia(2001)49 cited
- → Generating Virtual Patients by Multivariate and Discrete Re-Sampling Techniques(2015)46 cited
- → A Competitive Interaction Model Predicts the Effect of WAY-100,635 on the Time Course of R -(+)-8-Hydroxy-2-(di-n-propylamino)tetralin-Induced Hypothermia(2002)35 cited
- → Transdermal iontophoretic delivery of apomorphine in patients improved by surfactant formulation pretreatment(2004)34 cited
- → Phase IIa study of dabigatran etexilate in children with venous thrombosis: pharmacokinetics, safety, and tolerability(2017)34 cited
- → Pharmacokinetic-Pharmacodynamic Modeling of Buspirone and Its Metabolite 1-(2-Pyrimidinyl)-piperazine in Rats(2002)33 cited
- → Pharmacokinetics and Pharmacodynamics of Dabigatran 75 mg b.i.d. in Patients With Severe Chronic Kidney Disease(2016)30 cited
- → Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of Dabigatran Etexilate Oral Liquid Formulation in Infants with Venous Thromboembolism(2017)29 cited